KGOU

Alison Kodjak

The EpiPen, an injectable drug that reverses severe allergic reactions, just got a little cheaper for some consumers.

The device's manufacturer, Mylan NV, announced Thursday that it will offer coupons worth as much as $300 off a two-pack.

Editor's note: Updated at 9:20 am ET to include Mylan's announcement that it will reimburse consumers for some of their out-of-pocket costs.

EpiPens are in your friend's purse and your kid's backpack. The school nurse has a few, as does Grandma.

The medicine inside — epinephrine — has been around forever, and the handy gadget that injects it into your leg is not particularly new either.

The U.S. could rein in rising drug prices by being more selective about giving patents to pharmaceutical companies for marginal developments, a study concludes.

That's because brand-name drugs with patents that grant exclusivity account for about 72 percent of drug spending, even though they are only about 10 percent of all prescriptions dispensed, according to the study, published Tuesday in JAMA, the journal of the American Medical Association.

Insurance giant Aetna will stop selling health insurance through most of the exchanges created by the Affordable Care Act in 2017 because the company said it is losing money in many of those markets.

On Monday, Aetna said it will sell individual insurance policies in only 242 counties in four states, down almost 70 percent from the 778 counties in 15 states where the company markets Obamacare plans this year.

The battle continues to rage between drug companies that are trying to make as much money as possible and insurers trying to drive down drug prices. And consumers are squarely in the middle.

That's because, increasingly, prescription insurers are threatening to kick drugs off their lists of approved medications if the manufacturers won't give them big discounts.

Copycat versions of biotech drugs work just as well as the originals and cost a lot less, according to an analysis of studies of the medicines.

The analysis by researchers at Johns Hopkins Bloomberg School of Public Health finds that so-called biosimilars — medications that are meant to mimic, and compete with, complex and expensive biotech drugs — perform as well as the brand-name versions.

Maryland Medicaid officials have made what appears to be a small change to the list of preferred medications to treat opioid addictions. The agency used to pay for the drug in a dissolvable film form. Now it's steering patients to tablets, which some doctors say are not as effective for their patients.

Those doctors say the change is having a profound effect on some people struggling to stay clean.

The Senate on Wednesday overwhelmingly approved a bill intended to change the way police and health care workers treat people struggling with opioid addictions.

The bill, which had previously passed the House, will now be sent to President Obama. He has indicated that he will sign it, despite concerns that it doesn't provide enough funding.

Copyright 2018 NPR. To see more, visit http://www.npr.org/.

RENEE MONTAGNE, HOST:

And the Senate this morning is set to vote on a bill to address the epidemic of opioid addiction. NPR's Alison Kodjak reports the bill has many new policies, but not so much new funding to pay for them.

Obamacare health plans have been getting a bad rap this year. Critics say the premiums are too high, the out-of-pocket costs are out of control, and the requirements and red tape are too thick.

But now the Obama administration is pushing back.

A study released Tuesday by the Centers for Medicare and Medicaid Services argues that the cost-sharing isn't nearly as heavy as previous analyses have shown, because most consumers get subsidies that limit their deductibles and copayments.

Here's a typical scenario when you have a medical problem. You go to your doctor's office, then have to run across town to a lab for a blood test and then you also have to get an appointment for an X-ray or MRI. There's a good chance this will all require a phone call — or a lot of phones calls — with your insurance company.

It's a hassle and it's time-consuming.

But for many people it's even worse than that.

The Obama administration is making it easier for people addicted to opioids to get treatment.

Health and Human Services Secretary Sylvia Burwell announced new rules Wednesday to loosen restrictions on doctors who treat people addicted to heroin and opioid painkillers with the medication buprenorphine.

Lisa Lynn Kotnik has been a singer on the New Orleans club circuit for more than 15 years.

"I sang at Fritzel's for eight years," she says. "I sang at the Bombay Club for 15 years, I sang at Margaritaville — the list could go on and on and on."

While Kotnik sings to revelers at night under the stage name Lisa Lynn, in the daytime she's battled health problems — fibroids, ovarian cysts, a hysterectomy and even a brain aneurysm.

Bullying and cyberbullying are major risk factors for teen suicide. And both the bullies and their victims are at risk.

That's according to a report from the American Academy of Pediatrics that urges pediatricians and family doctors to routinely screen teenagers for suicide risks.

People who die in the hospital undergo more intense tests and procedures than those who die anywhere else.

An analysis by Arcadia Healthcare Solutions also shows that spending on people who die in a hospital is about seven times that on people who die at home.

The first time Ray Tamasi got hit up by an investor, it was kind of out of the blue.

"This guy called me up," says Tamasi, president of Gosnold on Cape Cod, an addiction treatment center with seven sites in Massachusetts.

"The guy" represented a group of investors; Tamasi declines to say whom. But they were looking to buy addiction treatment centers like Gosnold.

Public health advocates who are exasperated by the fight on Capitol Hill over how much to spend to combat the Zika virus are looking longingly at the Federal Emergency Management Agency.

FEMA has a standing fund that it can draw upon when disaster strikes. The fund is replenished when the money is spent cleaning up from hurricanes, tornadoes and other natural disasters.

The next generation of senior citizens will be sicker and costlier to the health care system over the next 14 years than previous generations, according to a new report from the United Health Foundation. We're talking about you, baby boomers.

The report looks at the current health status of people ages 50 to 64 and compares them to the same ages in 1999.

While Congress fidgets over whether and how to pay for the fight against the Zika virus, state and local health departments are scrambling and slimming down.

That's because these front-line public health agencies have already seen their budgets chopped because of the debate.

Hillary Clinton is floating a proposal to let people over the age of 50 "buy in" to Medicare, the federal government's health insurance for those 65 and older.

The Democratic presidential contender mentioned the idea earlier this week at a campaign event in Stone Ridge, Va. She was responding to a woman who said her health insurance premiums — which she bought on the individual market — rose more than $500 last year.

"What you're saying is one of the real worries that we're facing with the cost of health insurance," Clinton said. "The costs are going up in many markets."

Pages